Introduction
Simian immunodeficiency virus (SIV) comprises a family of lentiviruses that infect non-human primates. These viruses share important biological and genetic properties with human immunodeficiency virus (HIV), and SIV strains from sooty mangabey and macaque monkeys (SIV mac/smm ) have been widely employed in HIV\acquired immunodeficiency syndrome (AIDS) research, due to their ability to cause a range of clinical sequelae in macaques that approximate those seen in humans with AIDS. This review will provide a general overview of SIV infection and a discussion of SIV pathogenesis as it relates to the goal of understanding the disease processes that lead to AIDS ; particular emphasis will be placed on SIV mac/smm since this represents the most widely used experimental animal model for the pathogenesis of human AIDS.
General features of infection Primate lentivirus families
Primate lentiviruses identified so far fall into five distinct groups, based on sequence relatedness : SIV smm \SIV mac \HIV-2, SIV mnd \SIV l'hoest , SIV syk , SIV agm and HIV-1\SIV cpz (Fig.  1) . In most cases, it is believed that the viruses have become highly adapted to their host species over an extended period of time -resulting in the ability to establish productive but nonpathogenic infections. The induction of immunodeficiency disease is typically a hallmark of infection of a new host species, to which the virus has not adapted itself (Gao et al., 1999) .
Apathogenic natural infections
A high incidence of natural SIV infection occurs in wild populations of African green monkeys (Cercopithecus aethiops),
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0001-6179 # 1999 SGM BFFH captivity. Transmission in the wild occurs primarily through sexual activity and through male-male aggression (Jolly et al., 1996 ; Nerrienet et al., 1998 ; Phillips-Conroy et al., 1994) .
SIV does not cause illness in natural infections, despite continuous, high-level virus replication (Fultz et al., 1990 ; Kurth & Norley, 1996 ; Rey-Cuille et al., 1998) . However, disease can result when the virus is transferred to a new host species, with a correlation between severity of disease and level of virus replication (Hirsch et al., 1995 ; Lowenstine et al., 1986 ; Murphey-Corb et al., 1986 ; Ohta et al., 1988) . Several studies have sought to define parameters associated with apathogenic infections in natural hosts in order to understand better pathogenic infections of new host species, such as humans. To this end, investigators have focused particular attention on host responses to infection and on the rate and nature of virus genetic evolution.
A lower rate of virus evolution was found in rhesus macaques infected with SIV smm* than in sooty mangabeys. This suggested that the natural host (mangabeys) might exert only a very modest selective pressure on the virus (Courgnaud et al., 1998) . In contrast, broader and more sustained cytotoxic T lymphocyte (CTL) activity was detected in mangabeys infected with SIV mac#$* , as compared to rhesus macaques (Kaur et al., 1998) . These apparently conflicting results highlight the difficulty inherent to studies of this kind, particularly when working with virus strains which have been selected for their virulence in ' unnatural ' hosts such as the rhesus macaque.
Other differences in host immune responses to infection have also been detected in infections of natural and new host species. Two groups have noted the absence of virus trapping on follicular dendritic cells in the lymph nodes of naturally infected animals (Beer et al., 1996 ; Rey-Cuille et al., 1998) , suggesting that the trapping of immune complexes on the surface of dendritic cells may contribute to destruction of lymph node architecture in pathogenic infections (Kurth & Norley, 1996) . In conjunction with this, unusually low levels of antibody to Gag, which could participate in immune complex formation, were found in SIV agm -infected African green monkeys (Norley et al., 1990 ).
Infections of the neonate
As is the case for adults, infection of neonates with hostadapted variants is apathogenic (Beer et al., 1998) , while accelerated disease progression may occur following crossspecies virus transmission (Baba et al., 1994 ; Bohm et al., 1993 ; Marthas et al., 1995) . In macaques, vertical transmission of SIV is relatively uncommon, and occurs primarily from ingesting virus-infected milk, as protective levels of maternal antibody wane (Otsyula et al., 1995 ; Phillips-Conroy et al., 1994) . This raises intriguing questions concerning the route of virus entry following oral exposure to infectious virus. Recent studies by O'Neil and colleagues suggest that orally delivered virus may in fact be capable of traversing the stomach, and of infecting lymphoid cells in the gastrointestinal mucosa (S. O'Neil, personal communication).
Transmission of natural and experimental infection
Experimental infection with SIV has been accomplished following oral, mucosal, intravenous and transplacental administration of virus (Baba et al., 1995 ; Neildez et al., 1998 ; Pauza et al., 1998 ; Ruprecht et al., 1998) . The efficiency of vaginal transmission increases during the luteal phase of the menstrual cycle (Sodora et al., 1998) and in animals treated with progesterone (Marx et al., 1996) . Transient viraemia may result from low dose vaginal inoculation (Miller et al., 1994) , but tissues from such animals may harbour SIV provirus despite the lack of detectable viraemia (McChesney et al., 1998) , and in one instance, transient viraemia following rectal inoculation resulted in subsequent virus reactivation and disease (Trivedi et al., 1996) .
Coreceptor usage
Like HIV, SIV requires CD4 and a coreceptor from the chemokine receptor family for infection. Both M-tropic and Ttropic strains of SIV use CCR5, although they bind to different domains of the molecule (Chen et al., 1997 ; Edinger et al., 1997 a ; Marcon et al., 1997) , while some HIV-2 strains can use CXCR4 (Hill et al., 1997) . Although signalling through the CCR5 receptor is not necessary for SIV infection (Edinger et al., 1997 a) , it has been suggested that events subsequent to virus entry may be affected by coreceptor binding (Chackerian et al., 1997) . This is supported by the fact that the envelope glycoprotein from an M-tropic SIV strain (SIV smmPBj".* ), but not from a T-tropic variant (SIV mac#$* ), was able to transduce intracellular signalling events upon binding to CCR5 (Weissman et al., 1997) .
Additional coreceptors also influence the tropism of SIV. For example, many SIV strains are able to replicate in the CCR5-negative CEMi174 cell line. This is thought to be due to the fact that CEMi174 cells express additional chemokine receptors, Bonzo (STRL33) and BOB (GPR15). Bonzo and BOB can serve as coreceptors for SIV, HIV-1 and HIV-2, and are both expressed in lymphoid tissues ; BOB is also expressed in colon (Deng et al., 1997) . Furthermore, some SIV strains, including a neurovirulent isolate, can directly infect brain endothelial cells via a CD4-independent, CCR5-mediated mechanism (Edinger et al., 1997 b) .
Primary, unpassaged SIV smm strains are unable to use BOB as a coreceptor, indicating that some adaptation to the use of receptors other than CCR5 may occur during in vitro passage (Chen et al., 1998) . This may be analogous to the conversion of primary M-tropic HIV-1 isolates into CXCR4-dependent, Ttropic strains upon prolonged passage in human T cell lines. Overall, the molecular determinants which influence SIV usage of coreceptor molecules are less well understood than those for HIV-1 -although they may be similar, since a single amino acid change in the V3 loop of the envelope protein of SIV mac#$* has been shown to impair its ability to enter CEMi174 cells, but not cells expressing CCR5 (Kirchhoff et al., 1997) .
Characteristics of pathogenic SIV infection Virus dissemination and early infection
Dissemination of SIV is rapid following rectal, vaginal or intravenous exposure. The gut-associated lymphoid tissue (GALT), which includes Peyer's patches, lamina propria lymphocytes and intraepithelial lymphocytes (IELs) is the largest lymphoid ' organ ' in the body and contains large numbers of highly susceptible activated CD4 + memory T cells, which may serve as a means for dissemination of virus to other tissues . Intravenous inoculation of rhesus macaques with SIV mac#$* has been shown to lead to severe depletion of CD4 + T cells in the gut within 7 days of virus inoculation . This preceded changes in the peripheral T cell compartment, and occurred at a time when there was a much greater number of infected cells within the GALT than in the peripheral lymphoid tissues.
Rapid virus dissemination also follows mucosal virus inoculation. Infected lymphocytes and Langerhans ' cells were found in the lamina propria of cervicovaginal mucosa and in T cell regions of internal iliac lymph nodes within 2 days of vaginal inoculation of rhesus macaques with the T-tropic virus strain, SIV mac#&" (Spira et al., 1996) . Recent studies have sought to examine more closely the first cellular targets of SIV infection, following mucosal infection. Studies by Hirsch et al. (1998) revealed that the majority of virus-infected cells detected within the first few days following rectal inoculation of rhesus macaques with an M-tropic SIV variant (SIV smPBj ) were in fact IELs (i.e. T cells). Far fewer virus-infected macrophages were detected at this very early stage of the infection process. These results suggest that T cells but not macrophages or dendritic cells may be the most common virus targets at the early stages of infection. Even so, macrophages may still be crucial to disease pathogenesis.
Comparative studies of the early replication of wild-type M-tropic SIV (SIV smPBj ) and an isogenic, vpx-deleted virus have shown that the two viruses were readily transmitted across the rectal mucosa and were equally efficient at infecting IELs (Hirsch et al., 1998) . However, the vpx-deleted virus was unable to undergo subsequent dissemination and did not cause high level viraemia, possibly because of its inability to productively infect macrophages (Hirsch et al., 1998) .
Depletion of CD4 M T cells
Pathogenic SIV infection causes a fatal immunodeficiency syndrome characterized by progressive depletion of CD4 + T lymphocytes, decreased responsiveness of peripheral blood lymphocytes to mitogen stimulation, thymic atrophy and opportunistic infections (Baskin et al., 1988 ; Benveniste et al., 1988 ; Letvin et al., 1985) . While it is clearly established that high plasma virus loads early in infection are predictive of rapidly progressive disease (Dittmer & Hunsmann, 1997 ; Hirsch et al., 1996 ; Ten Haaft et al., 1998 ; Watson et al., 1997) , understanding of the mechanisms for T cell depletion remains incomplete. There is good evidence that early changes in peripheral blood T cell populations are largely the result of changes in lymphocyte distribution (Schenkel et al., 1999) , which may occur in response to the secretion of proinflammatory cytokines by lymph node cells (Rosenberg et al., 1997 (Rosenberg et al., , 1998 . Studies have also shown that there is an increase in the turnover of both CD4 + and CD8 + T cells in SIV infection (Mohri et al., 1998 ; Rosenzweig et al., 1998) . However, these generalized changes do not account for the selective loss of CD4 + T cells, which is the hallmark of AIDS.
Activation-induced apoptosis has been evaluated as a mechanism of CD4 + T cell loss in AIDS. However, apoptosis occurs primarily in bystander cells, and affects both CD4 + and CD8 + T cells (Finkel et al., 1995 ; Gummuluru et al., 1996 ; Xu et al., 1997) . Apoptosis and depletion of thymic progenitors also occur early in infection of juvenile macaques, but the effect is transitory (Wykrzykowska et al., 1998) . Interestingly, a Nefdeleted mutant, SIV mac#$* , did not cause CD4 + T cell depletion in the GALT, but did cause marked activation of both CD8 + and CD4 + T cells, suggesting a critical role for Nef in T cell apoptosis . Consistent with this, SIV Nef has been shown to be essential for virally mediated upregulation of Fas ligand expression, and this has been proposed to represent a possible mechanism for virus immune evasion and induction of apoptosis (Hodge et al., 1998 ; Xu et al., 1997) .
Since FasL expression is regulated in response to T cell activation, and is controlled in part by the transcription factor nuclear activator of T cells (NFAT), one might anticipate that the NFAT-repressing, immunosuppressive drug cyclosporin A (CsA) could provide therapeutic benefits in the context of SIV infection. Unfortunately, CsA (which has a direct antiviral effect on HIV-1 but not SIV), did not alter disease progression in SIV-infected animals, though the time of peak antigenaemia was delayed slightly (Martin et al., 1997) . Similarly, CsA did not protect against fatal infection of pig-tailed macaques with SIV smmPBj"% (our unpublished results). Thus, the relationship between virally induced immune activation, apoptosis and disease pathogenesis remains rather uncertain.
SIV-induced enteropathy
Enteropathy, characterized by malabsorption, diarrhoea and weight loss in the absence of detectable secondary pathogens, is common in SIV infection (Heise et al., 1993 a, b ; Stone et al., 1994) . Proposed mechanisms include elevated production of pro-inflammatory cytokines, including IFN-γ and MIP-1β, by activated CD8 + T cells in the GALT (Smit-McBride et al., 1998) , as well as the depletion of IELs, which secrete cytokines and growth factors important in maintaining the integrity of the intestinal epithelium (Mattapallil et al., 1998) .
SIV-induced neuropathology
SIV infection is often accompanied by encephalitis, although opportunistic infections of the brain are uncommon (Desrosiers, 1990 ; Murray et al., 1992) . Frequent neuropathological findings include perivascular infiltration of macrophages, lymphocytic meningitis and multinucleated giant cells (Desrosiers, 1990 ; Lackner et al., 1991) . However, no correlation between the severity of clinical disease manifestations, such as motor and cognitive impairments, and the degree or location of neuropathological changes has been detected (Murray et al., 1992) . This has made further understanding of the neuropathogenesis of SIV infection somewhat difficult. In light of this, it is not surprising to note that the mechanisms which account for neuronal injury and dysfunction in SIVinfected macaques are poorly understood, and that while a substantial body of literature exists defining potential mediators of HIV-1 neurotoxicity, relatively little work has been done in the simian model (Dewhurst et al., 1996) . In spite of these drawbacks, SIV has proven valuable in broadening our understanding of the interaction between primate lentiviruses and the brain.
One area of active investigation concerns the mechanism(s) of virus entry into the central nervous system. SIV is known to enter the brain within the first few weeks of virus infection, but it remains unclear how this happens. One model proposes that SIV-infected monocytes are actively recruited to the brain by upregulation of monocytotropic chemokines and adhesion molecules, such as VCAM-1 (Sasseville et al., 1995 (Sasseville et al., , 1996 . However, direct evidence for chemokine-or cytokine-mediated recruitment of SIV-infected cells across the blood-brain barrier has not been shown, and no correlation between the expression of VCAM-1 and brain macrophage numbers has been detected (Lane et al., 1996) . It is therefore possible that other mechanisms, including the direct infection of brain endothelial cells, may contribute to the entry of SIV into the brain (Edinger et al., 1997 b ; Mankowski et al., 1994 ; Strelow et al., 1998) .
Efforts have also been directed at identifying viral and\or host factors that affect neurovirulence. Species differences may play a role, as the severity of neurological lesions was greater in pig-tailed macaques than in rhesus macaques inoculated with the same strain of SIV (Novembre et al., 1998 ; Zink et al., 1997) . Other factors which may contribute to virus neurovirulence include the virus host cell range and other virus genetic determinants. Thus, the ability to replicate in macrophages was acquired during brain passage of SIV mac#$* (Joag et al., 1995 ; Sharma et al., 1992) , but additional brain passage was required to attain neurovirulence. Evaluation of chimeric viral genomes constructed using the brain-passaged neurovirulent isolate and the parental SIV mac#$* clone revealed that the env and nef genes from the neurovirulent isolate were sufficient to confer neurotropism (Flaherty et al., 1997 ; Mankowski et al., 1997) . The requirement for nef in neurovirulence may be a function of its ability to incorporate a novel unidentified Nef-associated kinase (NAK) into virus particles (Barber et al., 1998 ; Flaherty et al., 1998) .
Virus and host determinants of pathogenesis Host determinants of pathogenesis
Host determinants which influence the pathogenesis of SIV infection include genetic, immune and innate factors. For example, neonatal animals show increased susceptibility to disease induction by SIV, as compared to adult macaques (Baba et al., 1995) . In addition, species-specific differences in the susceptibility of macaques to disease induction by SIV mac/smm have been reported, with pig-tailed macaques often showing accelerated kinetics of disease induction as compared to rhesus macaques (Hirsch et al., 1995 ; Rosenberg et al., 1991) . The reasons for this remain uncertain.
Taken as a whole, the mechanism(s) which contribute to antiviral immunity, and the evaluation of novel vaccination strategies represent one of the most intensively studied areas in SIV research. The reader is referred to a number of excellent reviews on this subject, which is largely beyond scope of the present review (Almond & Heeney, 1998 ; Geretti et al., 1998 ; Haigwood & Zolla-Pazner, 1998 ; Johnson, 1996 ; LambWharton et al., 1997) . With respect to the pathogenesis of SIV infection, and the role of host immune responses in regulating the outcome of infection, a few key points can be made. First, the temporal association between suppression of acute viraemia and emergence of detectable cellular and humoral immune responses against SIV suggests that the immune system is reasonably effective at limiting virus replication, at least in the early stages of SIV infection (Letvin et al., 1994 ; Reimann et al., 1994 ; Yasutomi et al., 1993) . Second, preexisting immunity can dramatically alter the outcome of infection, even if sterilizing immunity is not achieved. For example, macaques treated with a variety of immunogens have been shown to be fully or partially protected from the development of immunodeficiency disease following infection with live, pathogenic SIV, and to exhibit significantly reduced steady-state levels of virus in their blood, relative to untreated controls (Desrosiers et al., 1989 ; Gallimore et al., 1995 ; Giavedoni et al., 1993 ; Hirsch et al., 1994 Hirsch et al., , 1996 Israel et al., 1994 ; Lohman et al., 1994 ; Marthas et al., 1990 ; MurpheyCorb et al., 1991 ; Sutjipto et al., 1990) . Third, vaccine-induced SIV-specific CTL precursor frequency has been shown to correlate inversely with virus load after challenge (Gallimore et al., 1995) . This has provided support for the notion that virusspecific CTL responses are critical to the control of virus infection. Nonetheless, the requirements for protective antiviral immunity, and the relative contributions of CTL, antibody, cytokines and chemokines to immune protection remain poorly understood.
Virus genetic variation and immune evasion
Virus genetic variation in SIV-infected macaques has been studied, in an effort to understand virus responses to hostimposed selective pressures. In contrast to HIV-1, which contains dominant linear neutralizing epitopes in the highly variable V3 loop of gp120, the V3 loop of the SIV envelope glycoprotein is well-conserved (Overbaugh et al., 1991) . SIV envelope gene variation occurs principally in the V1 and V4 variable domains (Almond et al., 1993 ; Burns & Desrosiers, 1991 ; Overbaugh et al., 1991) , and conformation-sensitive antibody neutralization epitopes span both the conserved V3 region and the hypervariable V4 domain (Glamann et al., 1998 ; Javaherian et al., 1994 ; Kinsey et al., 1996) . This may allow the virus to successfully evade neutralizing antibody responses. CTL escape mutants have also been detected in SIV-infected macaques (Mortara et al., 1998) , as they have in HIV-1 infected humans, suggesting that multiple mechanisms may contribute to virus evasion of host immune responses, including Nefmediated effects on antigen presentation and FasL expression (see below).
Virus genetic determinants of pathogenicity
The SIV genome, like that of other lentiviruses, contains genes that are not essential for virus replication in cultured cell lines. For SIV, these genes are : vif, vpr, vpx and nef. Vpr and Vpx are related virion-associated proteins (Yu et al., 1990) . Neither Vpx nor Vpr alone is essential for disease induction by the T-tropic mac239 strain of SIV (Desrosiers et al., 1998 ; Gibbs et al., 1995 ; Hoch et al., 1995) , although deletion of both vpr and vpx has been shown to result in a high degree of attenuation of SIV mac#$* (Gibbs et al., 1995) . A somewhat different situation may pertain to M-tropic strains of SIV. In this case, vpx has been shown to be essential for efficient virus replication in macrophages (Fletcher et al., 1996 ; Yu et al., 1991) , possibly because of its role in the nuclear import of viral pre-integration complexes in non-dividing cells (Fletcher et al., 1996 ; Park & Sodroski, 1995) . Furthermore, deletion of vpx resulted in a dramatic attenuation of the pathogenicity of the M-tropic PBj14 strain of SIV smm (Hirsch et al., 1998) .
Evaluation of the pathogenicity of various deletion mutants of SIV mac#$* , and other virus strains, supports the following relative ranking of viral accessory genes in terms of their contribution to virus pathogenicity (from highest to lowest) : nef vpx vpr ; evaluation of the role of vif in virus pathogenicity is complicated by the fact that vif-deleted viruses grow very poorly in vitro and are only weakly infectious for macaques (Desrosiers et al., 1998) . One reason for the rather modest contribution of SIV Vpr to pathogenesis may be the fact that this protein carries out only one of the two major functional activities of its HIV-1 counterpart -namely, cell cycle arrest (Fletcher et al., 1996 ; Park & Sodroski, 1995) . Nonetheless, there is still strong selective pressure to maintain an intact vpr gene in SIV-infected macaques, since SIV mutants lacking a start codon for vpr underwent genetic reversion within 4-8 weeks of inoculation into rhesus macaques (Lang et al., 1993) .
Determinants of virus pathogenicity may reside not only in the protein-encoding regions of the viral genome, but also in the regulatory elements of the virus. The SIV mac#$* long terminal repeat (LTR) contains transcriptional regulatory elements which include a TATA box, four Sp1-binding sites and one NF-κB-binding site, as well as additional upstream elements not found in HIV-1. All of these elements were found to be dispensable for virus replication in PBMCs (Ilyinskii & Desrosiers, 1996) , and SIV mac#$* mutants lacking the Sp1 and NF-κB sites were able to cause immunodeficiency disease in rhesus macaques. However, none of these infected animals developed granulomatous pneumonia or encephalitis, possibly because of impaired virus replication in macrophages (Ilyinskii et al., 1997) . This would be consistent with in vitro findings, showing that the Sp1 or NF-κB sites within the LTR are required for replication of macrophage-competent derivatives of SIV mac#$* in macrophages (Bellas et al., 1993 ; Ilyinskii & Desrosiers, 1996) .
Role of Nef in SIV pathogenesis
The paramount importance of Nef in SIV pathogenesis has been apparent since Kestler et al. (1991) showed that macaques infected with a nef-deleted SIV mac#$* mutant remained diseasefree and maintained greatly reduced virus loads. For the purposes of the present discussion, we will focus our attention on functions of Nef that may play a role in virus pathogenicity, and on areas that remain controversial ; readers are referred to a recent review article for a more complete discussion on Nef (Harris, 1996) . SIV Nef is a 32-34 kDa myristoylated protein that is incorporated into virus particles (Bukovsky et al., 1997 ; Flaherty et al., 1998) . SIV Nef shares structurally conserved central domains with HIV-1 Nef, and diverges at its amino-and carboxy-termini (Iafrate et al., 1997) . In addition, HIV-1 and SIV Nef are functionally interchangeable within the context of chimeric viruses, when assessed for their ability to enhance the infectivity and replication kinetics of such viruses in cultured macaque and human PBMCs (Sinclair et al., 1997) . Nonetheless, important differences in the proteins exist, as revealed by the fact that chimeric simian-human immunodeficiency viruses containing SIV nef were more pathogenic in macaques than those containing HIV-1 nef (Shibata et al., 1997) .
Conserved functions of SIV and HIV-1 Nef include the ability to enhance the infectivity of virus particles, the alteration of lymphocyte activation events (Alexander et al., 1997 ; Iafrate et al., 1997) and the downmodulation of CD4 Fig. 2 . Schematic diagram of the interplay between SIV Nef and components of the T cell signalling machinery. The TCR is shown, with the various subunits denoted ; SIV Nef is known to interact directly with the zeta chain (ζ) (Bell et al., 1998 ; Howe et al., 1998) . TCR-associated tyrosine residues which comprise ITAM motifs that are involved in TCRmediated signalling events and the recruitment of the TCR-associated, T cell PTK Zap-70 are also shown (Y). As indicated by the arrow, a unique, ITAM-containing SIV nef allele (from SIV smmPBj14 ) has been shown to interact directly with Zap-70 (Luo & Peterlin, 1997) . In addition, Nef is known to interact with CD4, leading to the downregulation of cell surface expression of this molecule, with displacement of the CD4-associated tyrosine kinase, Lck (Foster et al., 1994 ; Garcia & Miller, 1991 ; Hua & Cullen, 1997 ; Iafrate et al., 1997) . Finally, SIV and HIV-1 Nef have also been shown to interact directly with Lck (Baur et al., 1997 ; Collette et al., 1996) .
from the surface of infected T cells (Foster et al., 1994 ; Garcia & Miller, 1991 ; Hua & Cullen, 1997 ; Iafrate et al., 1997) . While the contribution of these various functions to virus pathogenesis remains uncertain, considerable progress has been made in defining the biochemical pathways which may contribute to the various effects of Nef.
Recent results suggest that HIV-1 and SIV Nef may promote internalization of CD4 at least in part through a specific interaction with adaptor protein (AP) complexes involved in the recognition of protein sorting signals by the clathrin-dependent machinery (Greenberg et al., 1997 ; Le Gall et al., 1998 ; Piguet et al., 1998) . It is of interest to note that the ability of SIV Nef to bind to AP proteins is dependent upon a YxxL motif, which resembles tyrosine-based endocytotic sorting signals (Piguet et al., 1998) . This motif is absent in HIV-1 Nef, indicating that HIV-1 Nef must interact with the AP complex via a different, but unknown, mechanism.
SIV and HIV-1 Nef also interact specifically with a protein that appears to represent the catalytic subunit of the human vacuolar ATPase (Lu et al., 1998) . This may provide an alternative mechanism whereby Nef can target proteins to the endosomal pathway, and it suggests that Nef may alter cell surface protein expression in several ways. Indeed, Nef downmodulates the cell surface expression of MHC class I molecules, in a manner that may not depend on its interaction with AP complexes (Greenberg et al., 1998 ; Le Gall et al., 1998 ; Schwartz et al., 1996) . However, the in vivo relevance of this finding to virus pathogenesis is unclear -even though HIV-1 Nef-mediated downregulation of MHC has been shown to protect cells against CTL-mediated lysis in vitro (Collins et al., 1998) .
Additional properties associated with SIV Nef include an essential role in virally mediated induction of Fas ligand on T cells (Hodge et al., 1998 ; Xu et al., 1997) , as well as an association with a variety of cellular kinases (Harris, 1996) , including the CD4-associated protein tyrosine kinase (PTK) Lck (Baur et al., 1997) and, in the case of the SIV smmPBj"% Nef protein, the T cell receptor (TCR)-associated PTK, Zap-70 (Luo & Peterlin, 1997) (Fig. 2) . In many cases, the binding sites for these kinases have been mapped to short regions of the Nef protein. For example, the region of SIV smmPBj"% Nef which binds to Zap-70 is a tyrosine-based ITAM motif, which is essential for the acutely pathogenic and lymphoproliferationinducing phenotype of this virus (Du et al., 1995 (Du et al., , 1996 Luo & Peterlin, 1997 ; Saucier et al., 1998) .
A highly conserved SH3-binding domain (PxxP) that is found within both SIV and HIV-1 Nef has been shown to interact with cellular kinases, including the Src family of protein kinases and a cellular threonine\serine kinase, designated NAK (Collette et al., 1996 ; Manninen et al., 1998 ; Saksela et al., 1995) . NAK may represent a member of the p21-activated kinase (PAK) family of kinases, and its importance in virus pathogenesis has been examined through the use of mutated SIV genomes lacking the PxxP motif. Studies conducted by two different groups using identical SIV mac#$* mutants (PxxP AxxA) resulted in very divergent conclusions, but the data are in many respects similar. Lang et al. (1993) found that the AxxA mutant virus caused disease and death in 2\2 inoculated animals. They also found evidence of reversion of the AxxA mutation in 5-10 % of viral genomes present in tissues collected from these animals. Khan et al. (1998) also saw disease induction and death in macaques that they inoculated with their AxxA mutant, but they reported a much higher level of genetic reversion of the AxxA mutation (up to 70 %, in 5\6 chronically infected animals), and a functional restoration of NAK-binding activity. Thus, it would appear that there is strong selection for the PxxP motif in vivo. In addition, it is likely that this motif may be required for the induction of immunodeficiency disease, since the virus loads reported by Lang et al. (1993) were very high, meaning that even a low proportion of revertant virus (5-10 %) might have been sufficient to cause disease.
The effects of Nef on T cell signalling are, if anything, even more disputed and uncertain. A fairly substantial body of literature exists demonstrating the inhibition of T cell activation pathways by HIV-1 and SIV Nef (Baur et al., 1994 ; Collette et al., 1996 ; De & Marsh, 1994 ; Graziani et al., 1996 ; Greenway et al., 1995 ; Iafrate et al., 1997 ; Niederman et al., 1992) . On the other hand, some experiments suggest that Nef actually activates T cells (Alexander et al., 1997 ; Du et al., 1995 ; Hanna et al., 1998 ; Lindemann et al., 1994 ; Luo & Peterlin, 1997 ; Skowronski et al., 1993) . The question of the effects of Nef on T cells is further complicated by recent findings that SIV and HIV-2, but not HIV-1, Nef can interact with the zeta chain of the T cell receptor (TCR ζ ) (Bell et al., 1998 ; Howe et al., 1998) (Fig. 2) .
Conclusions and future directions
SIV-macaque models have proved to be highly useful in probing the pathogenic mechanisms that underlie the progression of acquired immunodeficiency disease. While considerable progress has been made, many important questions remain unresolved. These include the following : (1) why do viruses that are apathogenic in their natural hosts become virulent in new hosts (such as humans)? (2) What factors influence the level of virus replication and the ' set point ' of viraemia? (3) Why does the immune system ultimately fail in its efforts to contain virus replication, and can therapies designed to boost antiviral responses provide therapeutic benefit? (4) Can we more accurately map the virus determinants for pathogenesis, and can this information be used to develop new antiviral drugs (for example, drugs that might target viral accessory genes or drugs that specifically interfere with the ability of the virus to cause neurologic disease)? (5) Finally, can we use the SIV-macaque model to develop a safe and effective vaccine for AIDS? Work in our laboratories was supported by NIH grants to L. E. W. Necropsy findings in rhesus monkeys experimentally infected with cultured simian immunodeficiency virus (SIV)\delta. Veterinary Pathology 25, 456-467. 
